NueroMetrix, Inc.: An Interesting Micro-Cap Flyer? – Seeking Alpha

Seeking AlphaOn January 17, 2018, NueroMetrix announced a strategic partnership with GlaxoSmithKline plc. GSK paid NURO $5 million upfront and signed a partnership with up to $21.5 million in milestones. GSK will get the 100% ownership rights to NURO’s product … …read more Source:: MicroCap Stock News From Google News

from WordPress https://ift.tt/2GrcxXk
via IFTTT